Thymidylate synthase (TYMS)
Cofactors used
Clinical / pharmacological. Target of 5-fluorouracil (via FdUMP)
What it does, reaction by reaction
One-Carbon Metabolism (Folate Cycle) Amino Acid & Nitrogen Metabolism · Cytosol + mitochondrion
5,10-Methylene-THF + dUMP → dTMP + DHF
Converts 5,10-Methylene-THF dUMP into dTMP Dihydrofolate (DHF)
› Notes
Thymidylate synthase transfers and reduces a one-carbon unit to form dTMP, generating DHF. This is the committed one-carbon donation step for de novo thymidylate synthesis and is effectively irreversible; THF must be regenerated by DHFR for sustained DNA synthesis.
Deoxyribonucleotide Formation (Ribonucleotide Reductase pathway and thymidylate synthesis) Nucleotide Metabolism · Cytosol
dUMP → dTMP
› Notes
Thymidylate synthase (TYMS) catalyzes dUMP + 5,10-methylene-THF → dTMP + DHF. An active-site cysteine forms a covalent intermediate with dUMP, and 5,10-methylene-THF provides the methylene group and the reducing hydride equivalent; this is the committed, effectively irreversible step of de novo dTMP synthesis.
Pyrimidine De Novo Synthesis (through to UMP, then CTP/dTMP) Nucleotide Metabolism · Cytosol (one mitochondrial step)
dUMP → dTMP
› Notes
Thymidylate synthase (TYMS) catalyzes dUMP + 5,10-methylene-THF → dTMP + dihydrofolate (DHF). 5,10-Methylene-THF donates both the one-carbon unit and the reducing equivalents for conversion of C5 of uracil to the methyl group of thymine. This reaction is effectively irreversible and is the committed step in de novo thymidylate synthesis.
Showing all 3 reactions.
What accelerates and inhibits it
Regulation is pathway-specific, so each context is listed separately
Deoxyribonucleotide Formation (Ribonucleotide Reductase pathway and thymidylate synthesis)
Listed there as: Thymidylate synthase
dUMP and 5,10-methylene-THF availability
5-fluoro-dUMP (stable covalent ternary complex with 5,10-methylene-THF); product/pool feedback by dTMP/dTTP
S-phase/E2F-associated induction in proliferating cells rather than a direct hormonal switch.
One-Carbon Metabolism (Folate Cycle)
Listed there as: Thymidylate synthase
dUMP and 5,10-methylene-THF availability
5-fluoro-dUMP (with reduced folate forms); folate deficiency
Upregulated with cell-cycle/proliferative signaling rather than a single systemic hormone
Pyrimidine De Novo Synthesis (through to UMP, then CTP/dTMP)
Listed there as: Thymidylate synthase
dUMP and 5,10-methylene-THF availability
dTMP/dTTP feedback at the pathway level; 5-fluoro-dUMP forms a stable inhibitory ternary complex
Cell-cycle-dependent expression is increased in S phase through E2F-associated proliferation programs, rather than direct endocrine allostery.
Recent literature
Europe PMC · from cache · sorted by publication date
-
1
Microbiota as a modulator of drug response: targeting microbial-drug crosstalk in cancer therapy.
Zhao T, Liu M, Qiu L, Zhang H, Zhang N, Liu Z, Xia Z, Luo P, Huang J, Cheng Q. · 2026-04-10
open access unreviewed -
2
Exploring the gut microbiome and metabolomic interactions of antimetabolite drugs to optimize therapy.
Chen J, Wang Y, Xu L, Li X, Zhao L. · 2026-02-27
open access unreviewed -
3
Machine learning-assisted detection of canine mammary tumors using serum autoantibody signatures.
Lan B, Chang CY, Liu SW, Wu CC, Lai KM, Liu HP. · 2026-01-21
cited 1× open access unreviewed - 4
-
5
In Vitro Single-Cell Transcriptomic Profiling of Cultured Stem Cells From Apical Papilla and Dental Pulp Stem Cells: Unveiling Cellular Heterogeneity.
Shah MS, Sayegh MA, Khalil MM, Sundarabupathi M, AlKhnbashi O, Samaranayake L, Khyriem C, Sultana M, Egusa H,… · 2026-05-05
open access unreviewed -
6
Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.
Lutz F, Hannemann LS, Büyücek S, Möller K, Viehweger F, Schlichter R, Luebke AM, Kluth M, Hube-Magg C, Hinsch… · 2026-07-16
unreviewed -
7
Exploring Methyl-4-hydroxybenzoate-associated CDK1 dysregulation in breast cancer: A multi-omics investigation combining network toxicology, transcriptomics, and molecular dynamics.
Wang Y, Li J, Liu Z, Ding Y, Li H. · 2026-07-17
unreviewed -
8
Machine learning-based identification of lactate metabolism-associated biomarkers in non-alcoholic fatty liver disease.
Wang X, Wang X, Zhao L, Song L. · 2026-07-21
unreviewed -
9
Fluoropyrimidine Cardiotoxicity: Role of Uridine Triacetate and Pharmacogenomic Insights from a Case of 5-FU-Induced Cardiogenic Shock.
Filomia S, Del Buono MG, Saponara G, Aurigemma C, Marano R, Moliterno E, Tortora G, Minucci A, Salvatore L, S… · 2026-07-06
unreviewed -
10
Exploring the molecular association between Di(2-ethylhexyl)phthalate and dilated cardiomyopathy based on interpretable machine learning and molecular docking.
Xia X, Hu L, Tao S, Li J, Huang X. · 2026-01-22
unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.